![]() Some of Orbita customers and partners include AmWell, Cancer Treatment Centers of America, Cognizant, Mass General Brigham, and Mayo Clinic. Orbita's powerful conversational AI platform enables healthcare organizations to cost-effectively create and manage HIPAA-compliant virtual healthcare assistants for consumer and clinical applications that increase patient engagement, reduce cost of care, and improve outcomes. We're very proud of the work we've done and are equally proud to receive the support of our new investors to expand our reach and impact."įounded in 2015, Boston-headquartered Orbita provides award-winning voice and chat solutions for healthcare and life sciences sectors. We've experienced this perhaps most significantly in recent weeks supporting the COVID-19 pandemic response. "Thanks to our customers and partners, we've witnessed how virtual healthcare assistants based on our technology have improved both healthcare efficiency and quality. "Our mission has always been to transform lives through the power of voice and conversational AI," said Bill Rogers, CEO at Orbita. We are very pleased to continue supporting their progress." "The Orbita team quickly recognized how to apply their existing technology to deliver highly relevant solutions to the COVID-19 front-line response," said Taha Jangda, Partner at HealthX Ventures. "In addition to their rapid turnaround with the COVID chatbot, they have made tremendous strides expanding into the life sciences market, where they are well-positioned to facilitate patient engagement and marketing in a post-COVID world. Through these and its other offerings, the company reports that its technology is now reaching millions of individuals worldwide. The company has since released additional capabilities to target the evolving demands of the pandemic, including automated health monitoring for patients, employees, and other at-risk populations. Centers for Disease Control and Prevention (CDC). In March, Orbita announced a free COVID-19 chatbot designed to automate symptom screening and question-answering using content sourced from the U.S. In the past few months, Orbita has responded to an unprecedented number of requests related to COVID-19 from both existing and prospective customers across the globe. ![]() ![]() ![]() "We aim to partner with and invest in promising digital health companies complementary to Philips strategic initiatives and Orbita has established itself as a leading innovator in the industry with products and solutions that are enterprise-ready, pressure tested, and highly relevant to the pressing needs of healthcare providers." "Philips views conversational AI through voice and chatbot as an important future enabler to drive patient experience and clinical efficiency, especially in light of the current COVID-19 pandemic," said Rich Wilmot, Head of Philips Health Technology Ventures Global. Orbita's enterprise-grade conversational platform supports AI-powered voice and chatbot applications accessible across web, mobile, SMS, smart speakers (Amazon Alexa and Google Assistant devices), and conventional phone. Orbita's award-winning voice and chatbot platform is used by leading healthcare, life sciences, and medical technology companies to improve patient care and clinical efficiency. Promote safer workplaces through the COVID-19 pandemic with conversational health assessments and educational tools for employees.
0 Comments
Leave a Reply. |